Dr. Karin Irene Armstrong, MD

Dr. Armstrong practices at Minnesota Oncology Hematology, PA in Saint Paul, Minnesota.

Dr. Armstrong's NPI, 1730116088, was assigned on June 26, 2006. Dr. Armstrong graduated from Temple University School of Medicine in 2000. Dr. Armstrong holds Minnesota license 50374.

Dr. Armstrong's primary practice is Minnesota Oncology Hematology, PA, at 1580 Beam E Ave, Saint Paul, MN 55109 in Ramsey County. The practice phone is (651) 779-7978.

Dr. Armstrong's primary practice is Minnesota Oncology Hematology, PA in Saint Paul, Minnesota. Dr. Armstrong is also affiliated with United Hospital. The medical group on file is Buffalo Hospital. Dmand AI also links Dr. Armstrong to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Armstrong practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Armstrong's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Armstrong is licensed in Minnesota.

CMS data shows 12,900 Medicare services from Dr. Armstrong across 36 procedure codes in 2024, for 322 Medicare patients. Medicare paid $115,150 for them. Every service was in an office.

CMS counts 322 Medicare patients who saw Dr. Armstrong in 2024. The largest group is 65 to 74, with 144 patients. 65% of them have high blood pressure, and 59% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Armstrong's median patient age at 69, with 69% women.

In 2024, Dr. Armstrong wrote 862 Medicare Part D claims for 168 patients. 79% of them were for generic drugs. CMS names the drug for 685 of them, across 24 drugs with 11 or more claims each, at $1,921,612 in total drug cost. In 2023, CMS named 518 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Armstrong for performance year 2024, reported through an alternative payment model (APM). Dr. Armstrong accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Armstrong in 2017. Dr. Armstrong's most frequent co-authors are Thomas J. Fitzgerald, MD, PhD, Shalom Kalnicki, MD and Daniel Moriarty, MD.

CMS Open Payments shows 6 general payments to Dr. Armstrong from 5 drug and device companies from 2020 to 2022. Grants make up the largest share, 62% of the total. Allergan Inc. paid the most, $120.

Dr. Armstrong graduated from Temple University School of Medicine in 2000.